Michael Taylor
InvestorOperating Partner at Mission Biocapital · Executive at Deciphera Pharmaceuticals · Director at Telo Therapeutics, Inc. · Executive Chairman at ARase Therapeutics
Cambridge
Find your path to Michael
333 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.
Olga PrufetaunlockedMichael: together at Mission Biocapital (2020–2026)
×9Michael: together at Mission Biocapital
×2Michael: together at University at Buffalo
About
Operating Partner providing management and operational leadership to portfolio companies, serving as Executive Chairman at ARase, Telo, Mitokinin, and Epiodyne. Former President and CEO of Deciphera Pharmaceuticals and CEO of Ensemble Therapeutics. Holds a PhD in Medicinal Chemistry from SUNY Buffalo.
Executive at Deciphera Pharmaceuticals
Intro paths
→
In turn, Michael can intro founders to Deciphera Pharmaceuticals's investors below.
Deciphera Pharmaceuticals's investors · 3
Co-founders at Deciphera Pharmaceuticals
DF
Daniel F. Flynn, Ph.D.Executive Officer
Director at Telo Therapeutics, Inc.
Intro paths
→
In turn, Michael can intro founders to Telo Therapeutics, Inc.'s investors below.
Telo Therapeutics, Inc.'s investors · 1
Co-founders at Telo Therapeutics, Inc.
RB
Rob BellFounder
Executive Chairman at ARase Therapeutics
Intro paths
→
In turn, Michael can intro founders to ARase Therapeutics's investors below.
ARase Therapeutics's investors · 2
Co-founders at ARase Therapeutics
PC
Paul ChangPresident, CEO / CSO and Lead Founder
WL
W. Lee KrausScientific Founder
Experience
- Mission BioCapitalOperating Partnercurrent2020 — present
- Deciphera PharmaceuticalsDirector2014 — 2021
- Deciphera Pharmaceuticals, Inc.Senior Advisor2019Waltham, Massachusetts
- Deciphera Pharmaceuticals, Inc.President & CEO2014 — 2019Waltham, Massachusetts
- Ensemble Therapeutics Corp.President & CEO2007 — 2013
- Marina BiotechDirector2010 — 2012
- Cequent PharmaceuticalsDirector2008 — 2010
- PfizerSenior Vice President2000 — 2007
- PfizerDrug Development Vice President1983 — 2000
- Parke-Davis Pharmaceutical ResearchDrug Development VP1998 — 2000
Skills & more
Medicinal Chemistry3Biomarkers2Strategy9Drug Discovery12Drug Development22Lifesciences6Clinical Development7Biotechnology10Molecular Biology1Pharmaceutical Industry9Oncology3Genomics1
+3 more
Technology TransferAssay DevelopmentBiopharmaceuticalsFrom Michael's professional profile.
Deals · 1
Telo Therapeutics, Inc.Board seat
via Mission Biocapital · filed Jun 2022 · $10.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Frequently asked questions
- Who is Michael Taylor?
- Operating Partner providing management and operational leadership to portfolio companies, serving as Executive Chairman at ARase, Telo, Mitokinin, and Epiodyne. Former President and CEO of Deciphera Pharmaceuticals and CEO of Ensemble Therapeutics. Holds a PhD in Medicinal Chemistry from SUNY Buffalo.
- Where does Michael Taylor work?
- Michael Taylor is Operating Partner at Mission Biocapital and Executive at Deciphera Pharmaceuticals and Executive Chairman at ARase Therapeutics.
- What boards does Michael Taylor sit on?
- Michael Taylor holds tracked board seats at Telo Therapeutics, Inc..
- Where did Michael Taylor go to school?
- Michael Taylor studied at University of Pennsylvania (Post-Doc, Organic Chemistry); University at Buffalo (Ph.D., Medicinal Chemistry); University of South Florida (B.S., Chemistry).
Same school
Also attended University of Pennsylvania1,233
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,227 more
Also attended University at Buffalo106
Ariel LebowitsCFO at FJ LabsRyan ScottInvestor at Khosla VenturesLinda SinghInvestor at Golden SeedsBrian KangCo-Founder & Managing Director at Nautilus Ventures Management Company (Us), LlcKenneth K ThomasPrincipal at Backfuture Ventures, LlcDavid OppenheimerPartner, CFO at Verissimo Ventures
.jpg)
+ 100 more
Also attended University of South Florida62
Jay ParrishVenture Partner at ARCH Venture PartnersMarkInvestor at Yu GalaxyElias TorresInvestor at Array Ventures Management LlcJacob SmithSenior Associate: Helena Special Investments at Helena Special InvestmentsJonathan MercadoPrincipal at First Bight VenturesFrankie VinasSenior Portfolio Monitoring Analyst at Headline
+ 56 more
Shared employers
Also worked at Deciphera Pharmaceuticals2
Also worked at Cequent Pharmaceuticals2
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpact
+ 223 more